Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Hemorrhagic Brain Metastases in Renal Cell Carcinoma

Primary Cancers Associated with Hemorrhagic Brain Metastases

  • The Society for Neuro-Oncology identifies thyroid carcinoma as having a moderate hemorrhagic tendency 1
  • The Society for Neuro-Oncology identifies ovarian cancer as having a moderate hemorrhagic tendency 1

Characteristic Hemorrhagic Features

  • Renal cell carcinoma metastases demonstrate hyperintensity on T1- and T2-weighted images with loss of signal on T2*- or susceptibility-weighted imaging, the exact pattern described in this case 1, 2
  • Multiple small areas with signal loss on SWI represent hemosiderin deposition from prior hemorrhage, creating susceptibility artifact 1, 2

Pattern Recognition on MRI

  • The subcortical gray-white junction location is typical for hematogenous metastases 1

Why Other Options Are Less Likely

  • While lung cancer is the most common source of brain metastases overall, it does not have the same hemorrhagic propensity as RCC 1
  • Breast metastases can be hyperenhancing on arterial phase imaging, but only 10-26% show this pattern 3
  • Hemorrhagic breast metastases are uncommon compared to RCC 1
  • Multiple myeloma rarely metastasizes to the brain parenchyma 1
  • When CNS involvement occurs in multiple myeloma, it typically affects the dura or leptomeninges, not brain parenchyma 1
  • Squamous cell carcinomas do not have characteristic hemorrhagic propensity 1

Clinical Implications

  • Consider abdominal MRI with and without contrast if CT is equivocal, as RCC shows characteristic enhancement patterns 4, 5

Critical Pitfall to Avoid

  • The hemorrhagic nature on SWI is the key distinguishing feature that points specifically to RCC 1, 2